Germkill India launches Citrobioshield ffective against COVID 19

Germkill India announces launch of Citrobioshield – a natural and organic anti-infective agent effective against COVID 19. BRAINS hospital shares Citrobioshield’s effectiveness against SARS 2 virus and details of preclinical tests conducted.

Germkill India launches Citrobioshield ffective against COVID 19Bengaluru: The entire world is facing the challenge of Covid-19 disrupting health, social and economic status of a country. The number of people affected is alarmingly increasing posing a threat to life. Among the health workers, the mortality has been significantly high due to the constant exposure to the high viral load.  Since we do not have an effective anti-viral drug against the COVID 19, there is a need to depend on other safety measures to combat this menace.

In the light of the current situation, Germkill India have innovated a completely bio organic product “Citrobioshield” which has been time tested for anti microbial activity to be very effective against Covid 19. This was today announced in collaboration with BRAINS Hospital where this product has undergone detailed preclinical testing for the last three months and has been proven very effective.

Citrobioshield is 100% natural and organic

This fact has been tested extensively as per the international norms using the standard assessment measures stringently by the certified labs. The data is quite robust and supportive of the fact that citrobioshield has an effective viricidal activity especially against Covid 19. Therefore, this innovative product can be used at all healthcare as well as high risk areas where community is  at risk to reduce the  viral load in the environment. This is a very unique product and highly effective in preventing and combating the Covid 19 illness by a simple process.

Germkill India launches Citrobioshield ffective against COVID 19Citrobioshield is 100% natural and organic broad spectrum, multipurpose antimicrobial with effective activity against SARS-CoV2 virus. This is Made-in-India antimicrobial, stable upto 108 degree centigrade and fulfills all the criteria for an ideal disinfectant while being safe for the environment, humans and animals. It is essentially an extract of citrus fruits containing sinensis and citrus reticulate (Bio flavonoids).  It is formulated and manufactured in Bangalore by Germkill India.

Citrobioshield is made by using only certified organic bio – degradable ingredients and manufactured according to the regulatory requirements of Govt of India. Citrobioshield is a Made-In-India product that has been extensively evaluated using international standards of testing (ASTM and EN standards) both in India and abroad.

Citrobioshield has a rapid onset and long lasting bactericidal, fungicidal and viricidal activity. The 10% Citrobioshield solution was completely viricidal for SARS-CoV2 with a contact time of just 10 minutes. It has been tested and found effective against many microorganisms of clinical significance (such as Methicillin resistant Staphylococcus aureus, Pseudomonas, Candida albicans, E Coli ,SARS-CoV2, HIV) in both laboratory and clinical settings.

Clinically tested  and completely safe:

This product has undergone detailed preclinical testing and has been shown to be non-toxic in animals by both oral and inhalation routes. Citrobioshield inhalation has been clinically tested in COVID19 patients and found to be completely safe. It is odorless, non-carcinogenic, non-mutagenic, non-irritant and not allergic. Citrobioshield is usually administered as fog using special equipment. The liquid will get evaporated as fog along with few droplets.   Citrobioshield fogging can therefore be easily adopted for regular disinfection at various places including hospitals, community gathering areas and closed spaces such as schools, offices etc,.

Since it is a biological product, non corrosive and non inflammable, it does not cause any damage to the epithelium nor  to the  sophisticated machines.  Hence, no displacement of equipment or people is required while fogging.  Together with broad spectrum antimicrobial activity, Citrobioshield can safely be used for disinfection and can be readily used at hospitals, wards, ICUs and operation theaters to disinfect surfaces, beds, instruments and ventilator tubings. Frequent fogging can be performed between the two procedures without delaying the routine work.

Citrobioshield retains robust viricidal activity, especially against SARS-CoV2 on surfaces including tiles and stainless steel. Citrobioshield is non toxic and not harmful for cleanroom environments and therefore suitable for BSL2 and 3 facilities that require stringent sterility measures. Citrobioshield is all in one solution, tested on viruses containing both lipid and non lipids , bacteria , fungi and resistant  spores. Hence, it is an ideal  agent that can be adopted in all healthcare locations, for its efficacy and ease of application.

Citrobioshield is a fresh ray of hope in the fight against the COVID 19. I am extremely happy that this product has good antiviral activity that can protect the personnel as well as environment. It is a matter of pride that this is a  make in India product from Bangalore,” says, Dr. R Nagaraja Naidu the inventor and Founder of Germkill India.

Dr.-N-K-Venkataramana-Founder-Chief-Neurosurgeon-SSNMC-BRAINS
Dr N K Venkataramana

Dr. R. Nagaraja further added, “The entire testing process has been conducted and validated as per the ICMR guidelines. Hence, we recommend that this should be adopted as a routine sterilization process as well as a preventive measure for the Covid 19 at all healthcare destinations. We sincerely request the Govt. of India and the respective state governments direct the authorities for such implementation.”

“Citrobioshield is an excellent and elegant product, simple to use, safe and effective.  It is our moral responsibility to protect the healthcare workers who are the frontliners in the battle of COVID 19. We are using this at our hospital extensively to protect the staff and also for sterilizing the  medical equipment and  ICUs” said Dr N K Venkataramana, Founder Chairman & Chief Neurosurgeon, BRAINS Hospitals.

Share this:

shugreek diabetes tablets-medifield

 

 

Share this:

Jodarin-pain-cream

 

 

Share this:

Magazines

SUBSCRIBE MAGAZINE

Click Here

error: Content is protected !!